Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

Planned Parenthood launches new U.S. breast health initiative

WASHINGTON (Reuters) - Planned Parenthood, a target of U.S. conservatives opposed to its abortion and birth control services, said on Monday it would use $3 million in donations to launch an initiative to fight breast cancer with expanded screenings and education.

Myriad wins gene patent ruling from US appeals court

(Reuters) - A U.S. federal appeals court has once again affirmed the right of Myriad Genetics Inc to patent two genes linked to breast and ovarian cancer, after the U.S. Supreme Court told it to take another look at the hotly contested case.

Quality-of-Life Problems Linger for Young Women

Difficulties with general health, chronic conditions, sex and more were shown to be long-term effects of breast cancer treatment for women diagnosed at age 50 or younger. 

T-DM1 Delays Time to Progression and Extends Survival

Results from the international EMILIA study suggest a new effective treatment for HER2 positive metastatic breast cancer, using trastuzumab (Herceptin) linked with the potent chemotherapy DM1.

Everolimus Gains FDA Approval for Metastatic Breast Cancer

Postmenopausal women with metastatic, hormone receptor-positive breast cancer may now be treated with everolimus (Afinitor) in combination with exemestane (Aromasin), following FDA’s recent approval of the tablet medicine.

FDA Approves Perjeta for Metastatic Breast Cancer

FDA approves pertuzumab (Perjeta) for use in treating HER2 positive metastatic breast cancer when combined with trastuzumab (Herceptin), an anti-HER2 medicine that targets a different part of the HER2 protein, and docetaxel (Taxotere), a type ofchemotherapy.

High-carb diet tied to breast cancer risk for some

NEW YORK (Reuters Health) - Older women who eat a lot of starchy and sweet carbohydrates may be at increased risk of a less common but deadlier form of breast cancer, a new study suggests.

Breast cancer cells can turn off key immune response: study

HONG KONG (Reuters) - Breast cancer cells can shut down a powerful immune response in the body, which allows the disease to spread to the patient's bones, researchers in Australia reported on Monday.

Most women return to work after breast cancer

NEW YORK (Reuters Health) - Women who were in the workforce before a breast cancer diagnosis often get back to their normal job routine after treatment, a study of Swedish women finds.

FDA approves Novartis drug Afinitor for breast cancer

(Reuters) - The U.S. Food and Drug Administration said on Friday it has approved Novartis AG's drug Afinitor to treat women with a certain type of breast cancer.

close